Isabel Bravo

1.5k total citations
30 papers, 473 citations indexed

About

Isabel Bravo is a scholar working on Virology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Isabel Bravo has authored 30 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 11 papers in Infectious Diseases and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Isabel Bravo's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (9 papers). Isabel Bravo is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (9 papers). Isabel Bravo collaborates with scholars based in Spain, Portugal and United Kingdom. Isabel Bravo's co-authors include Bonaventura Clotet, Josep M. Llibre, José Ramón Santos, Eugènia Negredo, Roger Paredes, Adrián Curran, Esteban Ribera, Daniel Podzamczer, José Moltó and Rui Medeiros and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Isabel Bravo

30 papers receiving 463 citations

Peers

Isabel Bravo
Stacey A. Rizza United States
Laurie Smaldone United States
Paul Leger United States
Wendy Bannister United Kingdom
Donna Marie L. Alvino United States
W. Mulder Netherlands
Jean Claude Dusingize United States
Stacey A. Rizza United States
Isabel Bravo
Citations per year, relative to Isabel Bravo Isabel Bravo (= 1×) peers Stacey A. Rizza

Countries citing papers authored by Isabel Bravo

Since Specialization
Citations

This map shows the geographic impact of Isabel Bravo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Bravo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Bravo more than expected).

Fields of papers citing papers by Isabel Bravo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Bravo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Bravo. The network helps show where Isabel Bravo may publish in the future.

Co-authorship network of co-authors of Isabel Bravo

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Bravo. A scholar is included among the top collaborators of Isabel Bravo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Bravo. Isabel Bravo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bravo, Isabel, et al.. (2024). Advanced practice in radiotherapy across Europe: stakeholders’ perceptions of implementation and evolution. Radiography. 30(3). 896–907. 2 indexed citations
3.
Bravo, Isabel, Merçé Boada, Oscar L. López, et al.. (2023). Modulation of inflammatory regulation by plasma exchange with albumin replacement revealed by deep plasma and CSF proteomic profiling of the AMBAR study. Alzheimer s & Dementia. 19(S21). 1 indexed citations
4.
Buttiġieġ, Sandra C., et al.. (2023). A Review of the Applicability of Current Green Practices in Healthcare Facilities. International Journal of Health Policy and Management. 12. 6947–6947. 19 indexed citations
5.
Bravo, Isabel, et al.. (2023). Advanced practice roles amongst therapeutic radiographers/radiation therapists: A European survey. Radiography. 29(2). 261–273. 14 indexed citations
7.
Bravo, Isabel, et al.. (2022). Digital skills of therapeutic radiographers/radiation therapists – Document analysis for a European educational curriculum. Radiography. 28(4). 955–963. 9 indexed citations
8.
Miranda‐Gonçalves, Vera, Ana Lameirinhas, Alexandre Pereira, et al.. (2020). JmjC-KDMs KDM3A and KDM6B modulate radioresistance under hypoxic conditions in esophageal squamous cell carcinoma. Cell Death and Disease. 11(12). 1068–1068. 38 indexed citations
9.
Delgado, Fernando, Isabel Bravo, Eduardo Murías, et al.. (2016). Endovascular treatment in the acute and non-acute phases of carotid dissection: a therapeutic approach. Journal of NeuroInterventional Surgery. 9(1). 11–16. 7 indexed citations
10.
Santos, José Ramón, Josep M. Llibre, Isabel Bravo, et al.. (2016). Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial. AIDS Research and Human Retroviruses. 32(5). 452–455. 8 indexed citations
11.
Santos, José Ramón, María Saumoy, Adrián Curran, et al.. (2015). The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial. Clinical Infectious Diseases. 61(3). 403–408. 96 indexed citations
12.
Llibre, Josep M., Isabel Bravo, José Ramón Santos, et al.. (2015). Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia. PLoS ONE. 10(6). e0128131–e0128131. 5 indexed citations
13.
Kawana‐Tachikawa, Ai, Josep M. Llibre, Isabel Bravo, et al.. (2014). Effect of Maraviroc Intensification on HIV-1-Specific T Cell Immunity in Recently HIV-1-Infected Individuals. PLoS ONE. 9(1). e87334–e87334. 11 indexed citations
14.
Santos, José Ramón, María Saumoy, Adrián Curran, et al.. (2014). Randomized, crossover, double‐blind, placebo‐controlled trial to assess the lipid lowering effect of co‐formulated TDF/FTC. Journal of the International AIDS Society. 17(4S3). 19550–19550. 5 indexed citations
15.
Santos, José Ramón, José A. Muñoz-Moreno, José Moltó, et al.. (2013). Virological Efficacy in Cerebrospinal Fluid and Neurocognitive Status in Patients with Long-Term Monotherapy Based on Lopinavir/Ritonavir: An Exploratory Study. PLoS ONE. 8(7). e70201–e70201. 22 indexed citations
16.
Bravo, Isabel, Raquel Catarino, Ana Luísa Teixeira, et al.. (2011). The Role of p73 G4C14-to-A4T14 Polymorphism in the Susceptibility to Cervical Cancer. DNA and Cell Biology. 31(2). 224–229. 17 indexed citations
17.
Bravo, Isabel, et al.. (2011). Biology Contributions Biological equivalence between LDR and PDR in cervical cancer: multifactor analysis usingthe linear-quadratic model. Journal of Contemporary Brachytherapy. 3(3). 134–141. 5 indexed citations
18.
Santos, José Ramón, Josep M. Llibre, Peré Domingo, et al.. (2010). Short Communication: High Effectiveness of Etravirine in Routine Clinical Practice in Treatment-Experienced HIV Type 1-Infected Patients. AIDS Research and Human Retroviruses. 27(7). 713–717. 5 indexed citations
19.
Imaz, Arkaitz, Josep M. Llibre, Marta Mora-Rillo, et al.. (2010). Efficacy and safety of nucleoside reverse transcriptase inhibitor-sparing salvage therapy for multidrug-resistant HIV-1 infection based on new-class and new-generation antiretrovirals. Journal of Antimicrobial Chemotherapy. 66(2). 358–362. 19 indexed citations
20.
Costa, Sandra, Daniela Pinto, Luísa Carvalho, et al.. (2004). TP73 alterations in cervical carcinoma. Cancer Genetics and Cytogenetics. 150(2). 116–121. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026